| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 30,734,000 | 30,571,000 | 31,076,000 | 31,342,000 | | Cost of Revenue | 12,478,000 | 12,242,000 | 12,923,000 | 13,070,000 | | | Gross Profit | 18,256,000 | 18,329,000 | 18,153,000 | 18,272,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,847,000 | 7,706,000 | 8,211,000 | 7,676,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,903,000 | 4,886,000 | 5,044,000 | 4,978,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,506,000 | 5,737,000 | 4,898,000 | 5,618,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31,000 | (15,000) | (498,000) | (81,000) | | Earnings Before Interest And Taxes | 5,768,000 | 5,859,000 | 4,507,000 | 5,794,000 | | Interest Expense | 879,000 | 849,000 | 813,000 | 858,000 | | Income Before Tax | 4,889,000 | 5,010,000 | 3,694,000 | 4,936,000 | | Income Tax Expense | 1,613,000 | 1,809,000 | 1,290,000 | 1,706,000 | | Minority Interest | (153,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,123,000 | 3,201,000 | 2,404,000 | 3,230,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,123,000 | 3,201,000 | 2,404,000 | 3,230,000 | | Preferred Stock And Other Adjustments | 75,000 | (75,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $3,198,000 | $3,126,000 | $2,404,000 | $3,230,000 |
|
0.17% Nasdaq 
0.01 (0.04%) 
Income Statement
